Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > EBITDA Bay Street

<< Previous

Bullboard Posts

Next >>

Comment by oilandgasmanon Sep 15, 2023 10:34am

126 Views

Post# 35638175

RE:RE:EBITDA Bay Street

No. I've seen deals like this fall way short of amature number crunching.
I'd add you have no clue how any deal might be structured or what the milestone payments have ment to that deal thus far.

It's shocking how personal you take this.

<< Previous

Bullboard Posts

Next >>

5 steps to mastering risk management in the stock market